Although this year’s flu season started early and promises to be challenging, the number of flu shots is lower than at the same time of year in previous seasons. The -19 vaccine also remains low about three months after it became available in early September.
To the knowledge of the Centers for Disease Control and Prevention (CDC), the flu vaccination rate has lagged in recent years since early October.
Based on mid-November data, flu vaccination rates in formative years are 40% through last year, but some state policy rates are lower than in the 2020-2021 and 2019-2020 seasons. Adult policy in all 50 states and Washington, D. C. , levels of 18. 9% to 35. 6%, according to the CDC, a low in recent years, when flu vaccination policy ranged from 45% to 50% among adults 18 years and older.
In a typical year, at most about 50 percent of eligible Americans can be expected to get a flu shot during the season. and going to the hospital to ease the burden of fitness systems and prevent deaths in vulnerable populations, as public fitness officials want.
As for COVID-19, as of November 15, just over 39. 7 million people in the U. S. The U. S. government had gained the updated bivalent booster, according to the CDC. That’s about 12. 7 percent of other people eligible for the vaccine, which includes everyone. over five years old.
The population over 65 years of age receives the bivalent vaccine in greater proportion than other age groups, with 32. 6%, or about 17. 8 million people, having received it.
This remains below the acceptance seen in initial coronavirus vaccination campaigns. In the United States, approximately 80% of eligible Americans gained at least one dose and just under 69% finished the number one series (i. e. , two doses of an mRNA vaccine).
Why is intake low?
It’s possible that these numbers partly reflect how other people think about their fitness and the potential benefits of a flu shot or coronavirus booster, experts suggest.
In a 2021 study published in Research in Social and Administration Pharmacy, researchers found that other seniors ages 18 to 49 were more hesitant about vaccines, as did others from low-income populations. They asked respondents questions, such as whether even a vaccine against the idea would help them. It helps, if they knew how it worked and if they even believed it was vital to protecting others. Of those who responded they wouldn’t get a flu shot, about 20 percent said they even believed the vaccine had given them the flu, even though vaccination doesn’t, and about 38 percent said they didn’t think it helped.
The researchers wrote about how the trend of fitness ideals might affect flu and COVID-19 vaccine absorption. interest and fear for fitness; express ideals in physical form about vulnerability to a specific physical fitness risk; and ideals about the consequences of the fitness problem,” according to a book by Academic Press.
This idea procedure can influence possible options in several ways. For example, each user can necessarily conduct a clinical trial with a pattern of one. flu and draw conclusions about the benefits that the vaccine can bring them at the user level.
In this way, the user acts as an individual researcher, collecting knowledge problems through their networks. This effect can be exacerbated when real-world knowledge is lagging behind or incomplete.
Knowledge of COVID-19 is also not as reliable or available as it used to be, which can negatively threaten calculations and threat perception. When knowledge is fragmented or unreliable, this calculation becomes much more confusing because “its threat is based on how well we perceive the strength of transmission and how much virus is around,” says epidemiologist Delivette Castor of Columbia University.
Erroneous data can also influence how other people think about flu shots. “There’s total social design to this in terms of access to data education,” says Anandi Law at Western Health Sciences University. “And then there are action signals, which is the kind of data you get from other places. And it can be just a means, it can be just a friend, it can be anywhere.
There may also be cognitive biases at play. A user may not forget only the instances that verify their confidence that the flu vaccine is useful or not. Or you may still have health problems after getting the vaccine, possibly leading them to think that the vaccine is rarely running too long or that it has caused them to get the flu.
The flu vaccine doesn’t make recipients sick, a person’s immune formula can be activated in response.
Another imaginable explanation for why early COVID-19 vaccination campaigns were more effective than the existing push for bivalent reinforcement is that there was still a pressing need to combat the pandemic when the first vaccines were rolled out.
“No matter where you were, you saw other people around you suffering, going into the hospital, dying,” Law says. “At the end of the day, self-preservation, without living, surpasses any other kind of conviction, whether political, whether of faith. “
Today, however, the general sense of urgency has faded for many people, possibly explaining why vaccination rates are low. The tens of thousands of new cases and hospitalizations and a slew of new deaths each day would not cause the same reactions as at the beginning of the pandemic.
There’s still a lot of work to be done to understand how other people handle data, how long one type of information stays stuck with other people, and then how public health officials can evolve their communication so that it remains objective and moral for others. people who make judgments based on that data, Castor says.
There are many reasons and data why a user may decide to get vaccinated. “We’ve learned a really key lesson in COVID, which is that not everyone makes decisions the same way,” Castor continues. To do is to really perceive what those constellations of points are at any given time, to deal with them. “They may also not be static and possibly replace a person or population over time.
It’s still unclear what the optimal purpose might be for coronavirus booster coverage. For influenza, even with the annual crusade efforts, the country still records an average of up to 60,000 deaths each year. it’s never going to get to 0 hesitations,” Law says.
LA COLLINE 1625 K STREET, NW SUITE 900 WASHINGTON DC 20006 | 202-628-8500 TEL. | 202-628-8503 FAX
© 1998 – 2022 Nexstar Media Inc. | All rights reserved.